Mass General President Peter L. Slavin, MD, says that, as an organization committed to heal, prevent injuries and promote good health, Mass General should be part of the national dialogue on the national epidemic of gun violence.
Genetic insights into rare diseases and new models of collaborative research that involve patients, clinicians, scientists and members of industry could produce much-needed new treatments.
Families whose loved ones have type 1 diabetes are stepping up to support Mass General researcher Denise Faustman, MD, PhD, who has found a potential breakthrough, now being tested in a clinical trial.
Excitement is growing for the promising potential of CAR-T cell immunotherapy, which was used to treat Harrison Morrow’s relapsing multiple myeloma.
A Mass General researcher who spent years studying how infectious diseases develop is using his expertise to develop a new approach to treating certain cancers.
The Dauten Family Center for Bipolar Treatment Innovation at Mass General seeks to advance treatment by creating a global epicenter for research, education and outreach.
Brain imaging data shows that regularly practicing meditation can reduce activity in the part of the brain involved with stress and anxiety in as little as eight weeks.
Elsie Taveras, MD, MPH, uses clinical and community-based research to address the causes of childhood health problems and reduce health disparities.
Mass General researcher Caroline Mitchell, MD, PhD, is studying how microbial changes in the female reproductive tract can lead to health complications across the lifecycle of women.
A new therapy that can accelerate and improve wound healing showed early progress at Mass General’s Vaccine and Immunotherapy Center.